Clinical Trial

The INVADE Study: INnominate Vein Approach for Central Catheterization in Difficult to cannulatE Patients

Study acronym: INVADE
Recruiting
View on ClinicalTrials.gov →
Summary
Most recent guidelines suggest central venous access must be performed with real-time ultrasound guidance, and the most recommended site for cannulation is internal jugular vein (IJV); however, it is recognized that evidence for other sites is, at present, limited. Besides, guidelines does not account for patients with small vein cross-sectional area and/or respirophasic collapse, which can make the procedure more difficult or even impossible. The investigators aim to compare three different insertion sites for central venous access, with real-time ultrasound guidance
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2020-02-09; most recent amendment 2026-03-10.
Status change: Completed → Recruiting 2026-03-10
Status change: Recruiting → Completed 2025-09-21
Trial Details
NCT Number NCT04265703
Lead Sponsor Hospital Civil de Guadalajara
Collaborators: Instituto Jalisciense de Cancerologia
Conditions Critical Illness
Enrollment 315 participants
Start Date 2024-02-27
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-03-12